Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter

A Zucchetto; E Tissino; Tanja Hartmann; A Chigaev; G Del Poeta; A Colombatti; V Gattei

doi:10.1158/1078-0432.CCR-16-0050

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter

A Zucchetto, E Tissino, Tanja Hartmann (Co-author), A Chigaev, G Del Poeta, A Colombatti, V Gattei

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Letter to the editor › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	3410-3411
Journal	CLINICAL CANCER RESEARCH
Volume	22
Issue number	13
DOIs	https://doi.org/10.1158/1078-0432.CCR-16-0050
Publication status	Published - 2016

Access to Document

10.1158/1078-0432.CCR-16-0050

Cite this

Zucchetto, A., Tissino, E., Hartmann, T., Chigaev, A., Del Poeta, G., Colombatti, A., & Gattei, V. (2016). Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter. CLINICAL CANCER RESEARCH , 22(13), 3410-3411. https://doi.org/10.1158/1078-0432.CCR-16-0050

Zucchetto, A ; Tissino, E ; Hartmann, Tanja et al. / Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter. In: CLINICAL CANCER RESEARCH 2016 ; Vol. 22, No. 13. pp. 3410-3411.

@article{ebfc99755aa14b8da9c6a103a0269978,

title = "Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter",

author = "A Zucchetto and E Tissino and Tanja Hartmann and A Chigaev and {Del Poeta}, G and A Colombatti and V Gattei",

note = "Hartmann: Paracelsus Med Univ, Ctr Oncol, Med Dept Hematol Med Oncol Hemostaseol Infect Dis, Lab Immunol & Mol Canc Res, Salzburg, Austria",

year = "2016",

doi = "10.1158/1078-0432.CCR-16-0050",

language = "English",

volume = "22",

pages = "3410--3411",

journal = "CLINICAL CANCER RESEARCH ",

issn = "1078-0432",

publisher = "Amer Assoc Cancer Research",

number = "13",

}

Zucchetto, A, Tissino, E, Hartmann, T, Chigaev, A, Del Poeta, G, Colombatti, A & Gattei, V 2016, 'Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter', CLINICAL CANCER RESEARCH , vol. 22, no. 13, pp. 3410-3411. https://doi.org/10.1158/1078-0432.CCR-16-0050

Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter. / Zucchetto, A; Tissino, E; Hartmann, Tanja (Co-author) et al.
In: CLINICAL CANCER RESEARCH , Vol. 22, No. 13, 2016, p. 3410-3411.

Research output: Contribution to journal › Letter to the editor › peer-review

TY - JOUR

T1 - Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter

AU - Zucchetto, A

AU - Tissino, E

AU - Hartmann, Tanja

AU - Chigaev, A

AU - Del Poeta, G

AU - Colombatti, A

AU - Gattei, V

N1 - Hartmann: Paracelsus Med Univ, Ctr Oncol, Med Dept Hematol Med Oncol Hemostaseol Infect Dis, Lab Immunol & Mol Canc Res, Salzburg, Austria

PY - 2016

Y1 - 2016

U2 - 10.1158/1078-0432.CCR-16-0050

DO - 10.1158/1078-0432.CCR-16-0050

M3 - Letter to the editor

C2 - 27371631

SN - 1078-0432

VL - 22

SP - 3410

EP - 3411

JO - CLINICAL CANCER RESEARCH

JF - CLINICAL CANCER RESEARCH

IS - 13

ER -

Zucchetto A, Tissino E, Hartmann T, Chigaev A, Del Poeta G, Colombatti A et al. Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter. CLINICAL CANCER RESEARCH . 2016;22(13):3410-3411. doi: 10.1158/1078-0432.CCR-16-0050